Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma

BACKGROUND: Oligonucleotide drug development has revolutionised the drug discovery field. Within this field, ‘small’ or ‘short’ activating RNAs (saRNA) are a more recently discovered category of short double-stranded RNA with clinical potential. saRNAs promote transcription from target loci, a pheno...

Descripción completa

Detalles Bibliográficos
Autores principales: Setten, Ryan L., Lightfoot, Helen L., Habib, Nagy A., Rossi, John J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204661/
https://www.ncbi.nlm.nih.gov/pubmed/29886828
http://dx.doi.org/10.2174/1389201019666180611093428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204661/
https://www.ncbi.nlm.nih.gov/pubmed/29886828
http://dx.doi.org/10.2174/1389201019666180611093428

Ejemplares similares